General information only, not legal or regulatory advice. Your patent counsel and regulatory team should make the final calls.
01
Where inventions show up in a device program
Inventions in medical devices are rarely limited to the core mechanism. Delivery systems, sensor placement, materials choices, sterilization-compatible designs, user interface safeguards and embedded software can all be candidates to discuss with counsel.
Design iterations driven by verification testing are a frequent source. A change made to pass a test often solves a problem competitors will face too.
What to get ready
- Review design history records for changes that solved a hard technical problem.
- List the features that drive clinical or usability advantages.
- Include embedded software and accessories, not just the main device.
Go deeper
02
Align filings with the regulatory timeline
Regulatory submissions, investor decks and partner discussions can all describe a device in detail. Many teams plan filing discussions with counsel ahead of these milestones so new features are considered before they are widely shared. Regulatory clearance and patent protection are separate questions, and one does not imply the other.
What to get ready
- Map upcoming submissions and announcements against open invention candidates.
- Schedule a counsel review before each major external milestone.
- Keep regulatory and IP teams aware of each other's calendars.
03
Clinical studies, publications and conferences
Clinical study results, abstracts and conference presentations can count as public disclosure. Timing rules vary by country, and some offer little or no grace period, so it helps to check with counsel before anything novel is presented.
What to get ready
- Route abstracts and posters past whoever owns IP decisions before submission.
- Confirm what study protocols and registries will make public.
Go deeper
04
Clinicians, hospitals and outside collaborators
Surgeons and clinicians often suggest the improvements that matter most. Who counts as an inventor is a legal question based on actual contribution, and ownership depends on the agreements in place, so these relationships benefit from clear written terms before ideas start flowing.
What to get ready
- Check that consulting and research agreements address invention ownership.
- Record who suggested what, and when, during advisory sessions.
- Ask counsel to review inventorship when outside contributors are involved.
Common questions
Does FDA clearance protect our device design?
No. Regulatory clearance or approval concerns safety and effectiveness. It does not create patent rights or stop competitors from developing similar products. Patent questions belong with licensed patent counsel.
When should we file relative to a regulatory submission?
Many companies discuss filing with counsel before a submission or public announcement describes new features. The right timing depends on your program and should be set with counsel.
Who owns ideas suggested by a consulting clinician?
That depends on the agreements in place and on who actually contributed to the invention. Counsel determines inventorship, and written agreements set ownership.
Do you work with medical device companies?
Yes. We work with mid-market and larger device companies to develop and document new inventions. Independent licensed patent counsel handles legal assessment and filing.
Is your device program generating inventions faster than you capture them?
We develop new inventions around your device roadmap and prepare materials for independent patent counsel to review and file.
Schedule a Strategy CallIdea Partnership is not a law firm and does not provide legal advice. This page is general information only. Consult licensed patent counsel about your specific situation.